Daily Newsletter

08 August 2023

Daily Newsletter

08 August 2023

UNSW Sydney engineers develop new app for Parkinson’s patients

The app provides instructions and provides encouragement through audio commentary.

RanjithKumar Dharma August 08 2023

Biomedical engineers from the University of New South Wales (UNSW Sydney) have developed a new app for training people with Parkinson’s disease (PD) to improve their gait.

Created with input from people with PD, the new Walking Tall app will enable those with the condition to learn to walk better and for longer.

Dr Matthew Brodie, a biomedical engineer at UNSW Sydney, led a team that developed the Walking Tall app after a clinical trial funded by the Michael J Fox Foundation for Parkinson's Research and the Shake It Up Australia Foundation.

During the trial, a section involved using the app's gait re-training feature, which now permits users to customise their training duration and pace.

Subsequently, the tool generates a rhythmic metronomic beat for three varying walking speeds, aimed at triggering movement.

Designed to be downloaded for free from the Android and iOS stores, the app offers instructions such as focus on 'big steps', 'walk tall' and 'shoulders back'. It also provides encouragement through audio commentary.

Brodie carried out the research at the advanced facilities of Neuroscience Research Australia in Sydney. The input and feedback from individuals with PD played a crucial role in shaping the app's development.

In the clinical trials with 62 PD patients, 50% used an app version to train their gait, while the rest followed the Otago Exercise Program (OEP) for walking improvement.

After 13 weeks, analysis of self-reported feedback from trial participants revealed that those following traditional OEP training exercised for an average of 60 minutes per week, while app users trained for 150 minutes.

Brodie said: "The app lowers the barriers for people with PD to train themselves to walk. We say to them that doing as little as six minutes a day, three days a week, will still help."

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close